These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24801282)

  • 41. Allosteric induction of the CD4-bound conformation of HIV-1 Gp120.
    Roitburd-Berman A; Dela G; Kaplan G; Lewis GK; Gershoni JM
    Retrovirology; 2013 Dec; 10():147. PubMed ID: 24304511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
    Koch M; Pancera M; Kwong PD; Kolchinsky P; Grundner C; Wang L; Hendrickson WA; Sodroski J; Wyatt R
    Virology; 2003 Sep; 313(2):387-400. PubMed ID: 12954207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.
    Brower ET; Schön A; Klein JC; Freire E
    Biochemistry; 2009 Feb; 48(4):779-85. PubMed ID: 19170639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.
    Grupping K; Selhorst P; Michiels J; Vereecken K; Heyndrickx L; Kessler P; Vanham G; Martin L; Ariën KK
    Retrovirology; 2012 May; 9():36. PubMed ID: 22551420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.
    Feng Y; McKee K; Tran K; O'Dell S; Schmidt SD; Phogat A; Forsell MN; Karlsson Hedestam GB; Mascola JR; Wyatt RT
    J Biol Chem; 2012 Feb; 287(8):5673-86. PubMed ID: 22167180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.
    Dowd CS; Leavitt S; Babcock G; Godillot AP; Van Ryk D; Canziani GA; Sodroski J; Freire E; Chaiken IM
    Biochemistry; 2002 Jun; 41(22):7038-46. PubMed ID: 12033937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteins.
    Lewis GK; Fouts TR; Ibrahim S; Taylor BM; Salkar R; Guan Y; Kamin-Lewis R; Robinson JE; Devico AL
    J Virol; 2011 Dec; 85(24):13097-104. PubMed ID: 21994452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.
    Hu G; Liu J; Roux KH; Taylor KA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
    J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.
    Rathore U; Purwar M; Vignesh VS; Das R; Kumar AA; Bhattacharyya S; Arendt H; DeStefano J; Wilson A; Parks C; La Branche CC; Montefiori DC; Varadarajan R
    J Biol Chem; 2018 Sep; 293(39):15002-15020. PubMed ID: 30093409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.
    Dennison SM; Anasti KM; Jaeger FH; Stewart SM; Pollara J; Liu P; Kunz EL; Zhang R; Vandergrift N; Permar S; Ferrari G; Tomaras GD; Bonsignori M; Michael NL; Kim JH; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Liao HX; Haynes BF; Alam SM
    J Virol; 2014 Aug; 88(16):9406-17. PubMed ID: 24920809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences.
    Li C; Dowd CS; Zhang W; Chaiken IM
    J Pept Res; 2001 Jun; 57(6):507-18. PubMed ID: 11437954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120.
    Gift SK; McFadden K; Zentner IJ; Rajagopal S; Zhang MY; Dimitrov DS; Chaiken IM
    Biochemistry; 2011 Apr; 50(14):2769-79. PubMed ID: 21417283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
    Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
    EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.
    Ferrer M; Harrison SC
    J Virol; 1999 Jul; 73(7):5795-802. PubMed ID: 10364331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
    Raja A; Venturi M; Kwong P; Sodroski J
    J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
    Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
    PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites.
    Acharya P; Luongo TS; Georgiev IS; Matz J; Schmidt SD; Louder MK; Kessler P; Yang Y; McKee K; O'Dell S; Chen L; Baty D; Chames P; Martin L; Mascola JR; Kwong PD
    J Virol; 2013 Sep; 87(18):10173-81. PubMed ID: 23843638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
    Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
    Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.